Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

Press Releases

All Releases
View Summary OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder
Mar 22, 2017
PDF 17.4 KB
View Summary OPKO Health's GeneDx to have Significant Presence at ACMG 2017
Mar 14, 2017
PDF 20.5 KB
View Summary OPKO Health to Participate in the Barclays Global Healthcare Conference
Mar 14, 2017
PDF 13.9 KB
View Summary OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder 
Mar 8, 2017
PDF 17.5 KB
View Summary OPKO Subsidiary GenPath Women's Health Announces the Availability of ClariTest™
Mar 7, 2017
PDF 17.9 KB
View Summary OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development
Mar 3, 2017
PDF 16.0 KB
View Summary OPKO Health Reports 2016 Financial and Operating Results
Mar 1, 2017
PDF 36.4 KB
View Summary OPKO Health's GeneDx Announces Participation in Illumina's iHope Program on International Rare Disease Day
Feb 28, 2017
PDF 18.8 KB
View Summary OPKO Health to Announce 2016 Fourth Quarter Financial Results on March 1, 2017
Feb 27, 2017
PDF 15.3 KB
View Summary OPKO Health to Participate at Upcoming Healthcare Investment Conferences
Feb 21, 2017
PDF 14.7 KB
View Summary OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis
Feb 8, 2017
PDF 16.0 KB
View Summary OPKO Health Promotes Thomas Nusbickel to Renal Division Chief Commercial Officer
Feb 7, 2017
PDF 69.2 KB
View Summary OPKO'S GeneDx Announces Research Collaboration with the Wellcome Trust Sanger Institute
Feb 1, 2017
PDF 21.2 KB
View Summary OPKO Investee Zebra Biologics Announces Collaboration with AbbVie to Discover New Antibody Therapeutics
Jan 10, 2017
PDF 17.5 KB
View Summary OPKO Announces Initiation of Claros® 1 Clinical Trial for Total PSA
Jan 9, 2017
PDF 16.6 KB
View Summary OPKO Health to Present at the J.P. Morgan 35th Annual Healthcare Conference
Jan 4, 2017
PDF 14.1 KB
View Summary OPKO Health Provides Update on hGH-CTP Clinical Programs
Dec 30, 2016
PDF 18.6 KB
View Summary OPKO Health to be Added to the NASDAQ Biotechnology Index
Dec 19, 2016
PDF 16.2 KB
View Summary OPKO Health to Participate at Three Investment Conferences in December
Nov 30, 2016
PDF 16.3 KB
View Summary OPKO Announces U.S. Launch of RAYALDEE™
Nov 23, 2016
PDF 67.8 KB
Showing 1-20 of 322 Page: 1 2 3 4 5 ... 17  Next 20

Email  Sign up for email alerts